Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers

BACKGROUND: Achievement of low-density lipoprotein cholesterol (LDL-C) goal is the most important for the patients with atherosclerotic cardiovascular diseases (ASCVD) who received lipid-lowering therapy. It is unclear that whether combination of ezetimibe with statin is superior to double-dose of s...

詳細記述

保存先:
書誌詳細
出版年:Lipids Health Dis
主要な著者: Wu, Na-Qiong, Guo, Yuan-Lin, Zhu, Cheng-Gang, Gao, Ying, Zhao, Xi, Sun, Di, Sun, Jing, Xu, Rui-Xia, Liu, Geng, Dong, Qian, Li, Jian-Jun
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6260646/
https://ncbi.nlm.nih.gov/pubmed/30470229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-018-0909-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料